Josef Mautner

5PUBLICATIONS
37CO-AUTHORS
Behavioural epidemiologyHaematological tumoursGene and molecular therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Major global burdens of disease
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 30, 2025
Assessing the fitness of Epstein-Barr virus following its reactivation.

Yen-Fu Adam Chen, Bianca Mocanu, Ezgi Akidil

|May 23, 2024
A metabolic dependency of EBV can be targeted to hinder B cell transformation.

Bojana Müller-Durovic, Jessica Jäger, Christine Engelmann

|May 29, 2020
The Epstein-Barr Virus Major Tegument Protein BNRF1 Is a Common Target of Cytotoxic CD4+ T Cells.

Dinesh Adhikary, Julia Damaschke, Josef Mautner

|Dec 07, 2018
Immunogenic particles with a broad antigenic spectrum stimulate cytolytic T cells and offer increased protection against EBV infection ex vivo and in mice.

Dwain G van Zyl, Ming-Han Tsai, Anatoliy Shumilov

|Jan 29, 2018
Epstein-Barr virus strain heterogeneity impairs human T-cell immunity.

Ana Cirac, Simon Stützle, Michael Dieckmeyer

Pageof 1

Frequent Collaborators

1 joint publications

Dwain G van Zyl

1 joint publications

Ming-Han Tsai

1 joint publications

Anatoliy Shumilov

1 joint publications

Rémy Poirey